Peptic Ulcer Drugs Market Demand Estimated to Witness High Growth Owing to Increased Incidences of Peptic Ulcers

Peptic ulcer drugs market demand are medications that help treat and heal ulcers found in the stomach and duodenum. Common peptic ulcer drugs include proton pump inhibitors, H2 blockers, and antibiotic combinations. Proton pump inhibitors are the most commonly prescribed drugs for peptic ulcers as they effectively reduce acid production in the stomach. The growing prevalence of peptic ulcers due to rising levels of stress and a unhealthy lifestyle has boosted the demand for peptic ulcer drugs.

The Global Peptic Ulcer Drugs market demand is estimated to be valued at US$ 34.34 Billion in 2023 and is expected to exhibit a CAGR of 4.1% during the forecast period (2023-2030).

Key Takeaways
Key players operating in the Peptic Ulcer Drugs are Daewoong, Takeda Pharmaceuticals, Pfizer, Abbott Laboratories, AstraZeneca.

Key players operating in the peptic ulcer drugs are Daewoong, Takeda Pharmaceuticals, Pfizer, Abbott Laboratories, AstraZeneca. The market presents opportunities for companies to develop novel drug formulations such as fixed-dose combinations, long-acting drugs, and drugs targeting Helicobacter pylori infection. The availability of generic drugs has also increased due to patent expiries of major drugs, thereby reducing treatment costs. Geographically, the market is dominated by North America but Asia Pacific is expected to witness highest growth owing to growing Incidences of peptic ulcers in countries like India and China.

Market drivers
The increased incidence of Peptic Ulcer Drugs Market Demand due to rising levels of stress, unhealthy diets, alcohol consumption and smoking is a major driver for this market. Moreover, growing geriatric population worldwide also contributes to the increased demand as elderly are more prone to developing peptic ulcers. Long term usage of NSAIDs for pain relief can also damage the stomach lining and cause peptic ulcers. Hence, increasing the sales of peptic ulcer drugs. Initiatives by governments and healthcare organizations to promote awareness about treatment of peptic ulcers will further support market growth during the forecast period.
PEST Analysis

Political: Regulations regarding drug approval and marketing authorization directly impact the peptic ulcer drugs market. Any changes in healthcare reforms and related policies affect the demand.

Economic: Changes in disposable income affect spending on healthcare and thereby influence sales of peptic ulcer drugs. Cost containment efforts of governments and insurance providers along with pricing pressure further impact market growth.

Social: Rising lifestyle diseases and changing dietary patterns leading to increased stress levels have enhanced the risk of peptic ulcers, driving adoption. Raising awareness through health programs boosts early diagnosis and treatment uptake.

Technological: E-commerce platforms improve access and online resources help patients educate themselves better. New drug delivery mechanisms and less invasive surgeries offer enhanced treatment effectiveness and convenience. Continued R&D aims to develop more targeted drugs.

Geographical regions where market in terms of value is concentrated:
North America holds the largest share owing to high healthcare spending, early adoption of new therapies, and incidence rates. North America is followed by Europe and Asia Pacific where the growing economies and patient pools contribute to significant market sizes.

The fastest growing region for the peptic ulcer drugs market:
Asia Pacific region is poised to witness the highest growth during the forecast period due to rising healthcare investments, increasing disposable incomes, growing incidence associated with changing lifestyles, and expanding medical tourism.

Get This Report In Japanese-

消化性潰瘍治療薬市場

Get This Report In Korean-

소화성 궤양 약물 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.

 ( https://www.linkedin.com/in/ravina-pandya-1a3984191 )